| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10285), 1637, 2021 | 1125 | 2021 |
| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 397 (10285), 1637-1645, 2021 | 387 | 2021 |
| Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10289), 2049, 2021 | 305 | 2021 |
| Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 399 (10320), 143-151, 2022 | 236 | 2022 |
| Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 399 (10320), 143, 2022 | 236 | 2022 |
| Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 400 (10349), 359-368, 2022 | 226 | 2022 |
| Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10274), 605, 2021 | 213 | 2021 |
| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial J Chalmers, H Abo-Leyah, H Loftus, M Spears, ... Lancet 397 (10285), 1637-1645, 2021 | 196 | 2021 |
| Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group The Lancet Respiratory Medicine 9 (12), 1419-1426, 2021 | 137 | 2021 |
| Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial E Abaleke, M Abbas, S Abbasi, A Abbott, A Abdelaziz, S Abdelbadiee, ... The Lancet 397 (10274), 605-612, 2021 | 121 | 2021 |
| Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 397 (10289), 2049-2059, 2021 | 111 | 2021 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 399 (10325), 665-676, 2022 | 77 | 2022 |
| Safety and efficacy of non‐steroidal anti‐inflammatory drugs to reduce ileus after colorectal surgery SJ Chapman, D Clerc, R Blanco‐Colino, A Otto, D Nepogodiev, A Soares, ... British Journal of Surgery 107 (2), e161-e169, 2020 | 56 | 2020 |
| Do medical students studying in the United Kingdom have an adequate factual knowledge of basic life support? RD Willmore, D Veljanoski, F Ozdes, B Stephens, J Mooney, SG Crumley, ... World journal of emergency medicine 10 (2), 75, 2019 | 40 | 2019 |
| Exploring UK medical school differences: the MedDifs study of selection, teaching, student and F1 perceptions, postgraduate outcomes and fitness to practise IC McManus, AC Harborne, HL Horsfall, T Joseph, DT Smith, ... BMC medicine 18 (1), 136, 2020 | 38 | 2020 |
| The Analysis of Teaching of Medical Schools (AToMS) survey: an analysis of 47,258 timetabled teaching events in 25 UK medical schools relating to timing … OP Devine, AC Harborne, HL Horsfall, T Joseph, T Marshall-Andon, ... BMC medicine 18 (1), 126, 2020 | 35 | 2020 |
| Psychology for medicine and healthcare R De Visser, SCSB Ayers Psychology for Medicine and Healthcare, 1-648, 2017 | 27* | 2017 |
| Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open … RECOVERY Collaborative Group Lancet (London, England) 401 (10387), 1499, 2023 | 26 | 2023 |
| Results from the MORPHEUS-liver study: Phase Ib/II randomized evaluation of tiragolumab (tira) in combination with atezolizumab (atezo) and bevacizumab (bev) in patients with … RS Finn, BY Ryoo, CH Hsu, D Li, A Burgoyne, C Cotter, ... Journal of Clinical Oncology 41 (16_suppl), 4010-4010, 2023 | 25 | 2023 |
| Safety of hospital discharge before return of bowel function after elective colorectal surgery ES Collaborative Journal of British Surgery 107 (5), 552-559, 2020 | 22 | 2020 |
